Advertisements



MannKind - Afrezza Scripts Start Out 2018 Modestly

MannKind - Afrezza Scripts Start Out 2018 Modestly.....»»

Category: topSource: seekingalphaJan 13th, 2018

MannKind: Afrezza Sales Start Off 2017 Modestly. Will A Bigger Sales Force Make A Material Difference?

MannKind: Afrezza Sales Start Off 2017 Modestly. Will A Bigger Sales Force Make A Material Difference?.....»»

Category: topSource: seekingalphaJan 17th, 2017

MannKind - Afrezza Scripts Crack 500

MannKind - Afrezza Scripts Crack 500.....»»

Category: topSource: seekingalphaDec 29th, 2017

MannKind - Afrezza Scripts Flat As Average Revenue Per Reported Script Stabilizes

MannKind - Afrezza Scripts Flat As Average Revenue Per Reported Script Stabilizes.....»»

Category: topSource: seekingalphaDec 16th, 2017

MannKind: Afrezza Scripts Recover From Holiday Week - What Investors Need To Know

MannKind: Afrezza Scripts Recover From Holiday Week - What Investors Need To Know.....»»

Category: topSource: seekingalphaDec 9th, 2017

MannKind"s Afrezza Scripts Dip On Holiday Week - Share Authorization Vote On Deck

MannKind"s Afrezza Scripts Dip On Holiday Week - Share Authorization Vote On Deck.....»»

Category: topSource: seekingalphaDec 2nd, 2017

MannKind: Afrezza Scripts And Revenue Rising - Is It Enough?

MannKind: Afrezza Scripts And Revenue Rising - Is It Enough?.....»»

Category: topSource: seekingalphaNov 25th, 2017

MannKind: Afrezza Scripts Remain Flat As Holiday Season Approaches

MannKind: Afrezza Scripts Remain Flat As Holiday Season Approaches.....»»

Category: topSource: seekingalphaNov 18th, 2017

MannKind - Afrezza Scripts Flat As Company Prepares For Q2 Conference Call

MannKind - Afrezza Scripts Flat As Company Prepares For Q2 Conference Call.....»»

Category: topSource: seekingalphaOct 30th, 2017

Currencies: Dollar holds ground at six-week highs

The dollar gained modestly for back-to-back sessions Tuesday, lifted by higher U.S. Treasury yields as relatively upbeat U.S. data to start the week strengthened the odds for dollar-supportive U.S. interest-rate hikes this year and into 2018......»»

Category: topSource: marketwatchOct 3rd, 2017

MannKind: Afrezza Scripts Remain Above 400 With FDA Label Decision Pending

MannKind: Afrezza Scripts Remain Above 400 With FDA Label Decision Pending.....»»

Category: topSource: seekingalphaSep 29th, 2017

MannKind: Afrezza Scripts Rebound To Highest Level Yet Under MannKind Control

MannKind: Afrezza Scripts Rebound To Highest Level Yet Under MannKind Control.....»»

Category: topSource: seekingalphaSep 22nd, 2017

MannKind - Afrezza Scripts Dip With Holiday Week - Cash Situation Remains In Focus

MannKind - Afrezza Scripts Dip With Holiday Week - Cash Situation Remains In Focus.....»»

Category: topSource: seekingalphaSep 15th, 2017

MannKind - Afrezza Scripts Finish August Flat

MannKind - Afrezza Scripts Finish August Flat.....»»

Category: topSource: seekingalphaSep 9th, 2017

MannKind: Afrezza Scripts Dip As Analyst Initiates Coverage With $4 Price Target

MannKind: Afrezza Scripts Dip As Analyst Initiates Coverage With $4 Price Target.....»»

Category: topSource: seekingalphaAug 11th, 2017

MannKind - Afrezza Scripts Dip

MannKind - Afrezza Scripts Dip.....»»

Category: topSource: seekingalphaAug 7th, 2017

MannKind: Afrezza Scripts Stable At A Bit Above 300 - Will Ads Help?

MannKind: Afrezza Scripts Stable At A Bit Above 300 - Will Ads Help?.....»»

Category: topSource: seekingalphaJul 21st, 2017

MannKind - Afrezza Scripts Remain Above 300 As Company Announces New CCO

MannKind - Afrezza Scripts Remain Above 300 As Company Announces New CCO.....»»

Category: topSource: seekingalphaJul 14th, 2017

MannKind: Weekly Afrezza Scripts Leveling Off Above 300

MannKind: Weekly Afrezza Scripts Leveling Off Above 300.....»»

Category: topSource: seekingalphaJul 7th, 2017

MannKind - Afrezza Scripts Come Back Down After ADA Conference Bump

MannKind - Afrezza Scripts Come Back Down After ADA Conference Bump.....»»

Category: topSource: seekingalphaJun 30th, 2017

MannKind: Afrezza Scripts Above 300 - Can Sales Keep Climbing?

MannKind: Afrezza Scripts Above 300 - Can Sales Keep Climbing?.....»»

Category: topSource: seekingalphaJun 19th, 2017